Pfizer stock gains as ELREXFIO win strengthens oncology case


Pfizer reports ELREXFIO trial success while Pfizer stock ...

Jefferies keeps a USD 36.00 target for Pfizer stock

Pfizer expands TALZENNA approval. Pfizer stock stands 1.81 ...

Pfizer stock stands 3.97 percent above USD 28.72 consensus ...

Pfizer reports 25-valent vaccine data. November 3 results ...

Pfizer Inc. stock lists analyst webcast November 3 2026 ...

Pfizer reports pediatric vaccine data: what it means for ...

Pfizer stock trades 0.26 percent below its Xetra close in ...

Pfizer stock: BofA raises target to USD 29 for Pfizer stock ...